MDSC and beyond: a symposium-in-writing on myeloid cells with immunoregulatory activity by members of the Mye-EUNITER network Sven Brandau Editorial 18 March 2019 Pages: 531 - 532
Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice Elodie PliquetClaude RuffiePierre Langlade-Demoyen Original Article 17 January 2019 Pages: 533 - 544
Adverse events need for hospitalization and systemic immunosuppression in very elderly patients (over 80 years) treated with ipilimumab for metastatic melanoma Vaianu LeroyEmilie GerardAnne Pham-Ledard Original Article 19 January 2019 Pages: 545 - 551
Immune checkpoint inhibitor-induced colitis as a predictor of survival in metastatic melanoma Hamzah Abu-SbeihFaisal S. AliYinghong Wang Original Article 21 January 2019 Pages: 553 - 561
Prognostic value of tumour-infiltrating CD8+ lymphocytes in rectal cancer after neoadjuvant chemoradiation: is indoleamine-2,3-dioxygenase (IDO1) a friend or foe? Julia SchollbachStefan KircherStefan Löb Original Article 22 January 2019 Pages: 563 - 575
A potential role for peripheral natural killer cell activity induced by preoperative chemotherapy in breast cancer patients Ryungsa KimAmi KawaiKoji Arihiro Original Article 23 January 2019 Pages: 577 - 585
Mutations resulting in the formation of hyperactive complement convertases support cytocidal effect of anti-CD20 immunotherapeutics Anna FelbergAleksandra UrbanMarcin Okrój Original Article Open access 06 February 2019 Pages: 587 - 598
The effect of anti-CTLA4 treatment on peripheral and intra-tumoral T cells in patients with hepatocellular carcinoma David AgdashianMei ElGindiFirouzeh Korangy Clinical Trial Report 28 January 2019 Pages: 599 - 608
Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma Sandra P. D’AngeloMatthias HungerMurtuza Bharmal Clinical Trial Report Open access 05 February 2019 Pages: 609 - 618
A pilot study of interferon-alpha-2b dose reduction in the adjuvant therapy of high-risk melanoma Lorena P. Suarez-KellyKala M. LevineWilliam E. Carson Clinical Trial Report Open access 06 February 2019 Pages: 619 - 629
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions Annika M. BrugerAnca DorhoiSven Brandau Symposium-in-Writing Paper 21 May 2018 Pages: 631 - 644
Interactions among myeloid regulatory cells in cancer Viktor UmanskyGosse J. AdemaZvi G. Fridlender Symposium-in-Writing Paper 12 July 2018 Pages: 645 - 660
Role of myeloid regulatory cells (MRCs) in maintaining tissue homeostasis and promoting tolerance in autoimmunity, inflammatory disease and transplantation Giada AmodioJoanna CichySilvia Gregori Symposium-in-Writing Paper Open access 24 October 2018 Pages: 661 - 672
MDSCs in infectious diseases: regulation, roles, and readjustment Anca DorhoiEstibaliz GlaríaAnnabel F. Valledor Symposium-in-Writing Paper 19 December 2018 Pages: 673 - 685
Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primates Luca CassettaEspen S. BaekkevoldGosse J. Adema Symposium-in-Writing Paper Open access 25 January 2019 Pages: 687 - 697
